Clinical trial
A Phase Ib Clinical Study of the Tolerance, Safety and Preliminary Efficacy Observation of Single-/Multiple- Doses of Metatinib Tromethamine Tablets in Patients With Advanced or Metastatic Solid Tumor
NCT02650375 is registered in ClinicalTrials.gov with Jiangsu Simcere Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Ib Clinical Study of the Tolerance, Safety and Preliminary Efficacy Observation of Single-/Multiple- Doses of Metatinib Tromethamine Tablets in Patients With Advanced or Metastatic Solid Tumor
- Lead sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- February 28, 2018
- Enrollment
- 24 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
advanced or metastatic crc, advanced or metastatic gastric cancer, advanced or metastatic liver cancer, advanced or metastatic non squamous nsclc